Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022-11-01
|
| Series: | JAAD Case Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2352512622004040 |
| _version_ | 1811225375915638784 |
|---|---|
| author | Michel Ntiri, BS Alessandra Haskin, MD Eve J. Lowenstein, MD, PhD |
| author_facet | Michel Ntiri, BS Alessandra Haskin, MD Eve J. Lowenstein, MD, PhD |
| author_sort | Michel Ntiri, BS |
| collection | DOAJ |
| first_indexed | 2024-04-12T09:06:11Z |
| format | Article |
| id | doaj.art-8da94b31369240be98145bf4db72d71b |
| institution | Directory Open Access Journal |
| issn | 2352-5126 |
| language | English |
| last_indexed | 2024-04-12T09:06:11Z |
| publishDate | 2022-11-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JAAD Case Reports |
| spelling | doaj.art-8da94b31369240be98145bf4db72d71b2022-12-22T03:39:06ZengElsevierJAAD Case Reports2352-51262022-11-01297679Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativaMichel Ntiri, BS0Alessandra Haskin, MD1Eve J. Lowenstein, MD, PhD2College of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New YorkDepartment of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New YorkCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York; Department of Dermatology, SUNY Downstate Health Sciences University, Brooklyn, New York; Correspondence to: Eve J. Lowenstein, MD, PhD, 450 Clarkson Ave, Box 46, Brooklyn, NY 11203.http://www.sciencedirect.com/science/article/pii/S2352512622004040directly observed therapy (DOT)disseminated tuberculosishidradenitis suppurativa (HS)infliximab therapylatent tuberculosismiliary tuberculosis |
| spellingShingle | Michel Ntiri, BS Alessandra Haskin, MD Eve J. Lowenstein, MD, PhD Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa JAAD Case Reports directly observed therapy (DOT) disseminated tuberculosis hidradenitis suppurativa (HS) infliximab therapy latent tuberculosis miliary tuberculosis |
| title | Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa |
| title_full | Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa |
| title_fullStr | Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa |
| title_full_unstemmed | Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa |
| title_short | Disseminated tuberculosis following negative QuantiFERON-TB gold tests during infliximab therapy: Implications for screening of hidradenitis suppurativa |
| title_sort | disseminated tuberculosis following negative quantiferon tb gold tests during infliximab therapy implications for screening of hidradenitis suppurativa |
| topic | directly observed therapy (DOT) disseminated tuberculosis hidradenitis suppurativa (HS) infliximab therapy latent tuberculosis miliary tuberculosis |
| url | http://www.sciencedirect.com/science/article/pii/S2352512622004040 |
| work_keys_str_mv | AT michelntiribs disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa AT alessandrahaskinmd disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa AT evejlowensteinmdphd disseminatedtuberculosisfollowingnegativequantiferontbgoldtestsduringinfliximabtherapyimplicationsforscreeningofhidradenitissuppurativa |